Novavax appoints chief scientific officer
Authority on vaccines, vaccine delivery and adjuvants
‘Greg Glenn is a recognised innovator and authority on vaccines, vaccine delivery and adjuvants,’ said Singhvi. ‘He brings to Novavax considerable experience in the discovery, development and clinical evaluation of a wide variety of vaccines.
‘As a co-founder of IOMAI, Greg also has an appreciation for the challenge of translating promising early-stage research into commercially viable, late-stage product candidates. We applaud his record of achievement and welcome his contributions to our future success.’
‘The use of virus-like particles to mimic live viruses is a very promising approach to preventing the spread of infectious diseases,’ Glenn said. ‘I look forward to supporting the development and application of this very promising approach to disease prevention.’
